The evolution and prospects of the gene expression profiling in colorectal cancer

Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical and Scientific Research 2023-10, Vol.12 (4), p.285-291
Main Authors: Srinivasamurthy, Banushree Chandrasekhar, Mathiyazhagan, Dharanya, Bhat, Ramachandra V.
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment and predicting the outcome of CRC. Several studies have been carried out to validate small to large signature genes that can predict the prognosis of CRC. The most commonly mutated genes in CRC include adenomatous polyposis coli (APC), TP53, KRAS and PIK3CA. The new challenge is translating the research outcome to clinical utility in patients of CRC. The coloprint, OncotypeDX, OncoDefender, ColoGuide Ex and ColoGuidePro are some of the proposed gene signatures available in CRC. In this study, we have reviewed the evolution and future prospects of proposed gene signature research published in PubMed indexed journals. The current article will provide an overview of the current developments in CRC.
ISSN:2277-5706
2277-8357
DOI:10.4103/jcsr.jcsr_92_22